192 related articles for article (PubMed ID: 17030097)
1. Environmental exposure to bacteria and viruses may provide oncolytic protection against cancers, and declining exposure to infections may contribute to a rising incidence of cancer.
Post A
Med Hypotheses; 2007; 68(3):558-61. PubMed ID: 17030097
[TBL] [Abstract][Full Text] [Related]
2. Lifestyle-related factors and environmental agents causing cancer: an overview.
Irigaray P; Newby JA; Clapp R; Hardell L; Howard V; Montagnier L; Epstein S; Belpomme D
Biomed Pharmacother; 2007 Dec; 61(10):640-58. PubMed ID: 18055160
[TBL] [Abstract][Full Text] [Related]
3. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
Sinkovics JG; Horvath JC
Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
[TBL] [Abstract][Full Text] [Related]
4. Infectious agents and cancer: criteria for a causal relation.
Pagano JS; Blaser M; Buendia MA; Damania B; Khalili K; Raab-Traub N; Roizman B
Semin Cancer Biol; 2004 Dec; 14(6):453-71. PubMed ID: 15489139
[TBL] [Abstract][Full Text] [Related]
5. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
6. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
Jenkins D
Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
[TBL] [Abstract][Full Text] [Related]
7. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
[TBL] [Abstract][Full Text] [Related]
8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response.
McElhaney JE
Expert Rev Vaccines; 2009 May; 8(5):593-606. PubMed ID: 19397416
[TBL] [Abstract][Full Text] [Related]
13. The infectious causes of cancer.
Campbell K
Nurs Times; 2006 Aug 15-21; 102(33):28-30. PubMed ID: 16937735
[TBL] [Abstract][Full Text] [Related]
14. [Oncolytic virus therapy for malignant brain tumors].
Ino Y; Todo T
Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859
[TBL] [Abstract][Full Text] [Related]
15. Monitoring and reducing exposure of infants to pollutants in house dust.
Roberts JW; Wallace LA; Camann DE; Dickey P; Gilbert SG; Lewis RG; Takaro TK
Rev Environ Contam Toxicol; 2009; 201():1-39. PubMed ID: 19484587
[TBL] [Abstract][Full Text] [Related]
16. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
17. Infections and cancer: established associations and new hypotheses.
de Martel C; Franceschi S
Crit Rev Oncol Hematol; 2009 Jun; 70(3):183-94. PubMed ID: 18805702
[TBL] [Abstract][Full Text] [Related]
18. An oncolytic virus derived from type 2 herpes simplex virus has potent therapeutic effect against metastatic ovarian cancer.
Fu X; Tao L; Zhang X
Cancer Gene Ther; 2007 May; 14(5):480-7. PubMed ID: 17290283
[TBL] [Abstract][Full Text] [Related]
19. Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways.
Naik S; Russell SJ
Expert Opin Biol Ther; 2009 Sep; 9(9):1163-76. PubMed ID: 19637971
[TBL] [Abstract][Full Text] [Related]
20. Lead contamination in Uruguay: the "La Teja" neighborhood case.
Mañay N; Cousillas AZ; Alvarez C; Heller T
Rev Environ Contam Toxicol; 2008; 195():93-115. PubMed ID: 18418955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
